2026-10-30 14:50:50 UTC#546470newconfirmednews
Alnylam Pharmaceuticals downgraded at Bernstein citing concerns over TRITON-CM trial design
seeking alphaimportance 0.40trust 0.70Alnylam Pharmaceuticals, Inc. -0.40Bernstein -0.20TRITON-CM -0.30
ALAB stock news. Deduplicated factual headlines, scored for importance, with entity sentiment and the sectors, countries, and asset classes affected. Updates open into the storyline.
See the full wire20 wire items